1.Neurologic Complications in Percutaneous Nephrolithotomy.
Abbas BASIRI ; Mohammad Hossein SOLTANI ; Mohammadreza KAMRANMANESH ; Ali TABIBI ; Seyed Amir MOHSEN ZIAEE ; Akbar NOURALIZADEH ; Farzaneh SHARIFIAGHDAS ; Mahtab POORZAMANI ; Babak GHARAEI ; Ardalan OZHAND ; Alireza LASHAY ; Ali AHANIAN ; Alireza AMINSHARIFI ; Mehrdad Mohammadi SICHANI ; Mohammad ASL-ZARE ; Faramarz Mohammad ALI BEIGI ; Vahid NAJJARAN ; Mehdi ABEDINZADEH ; Mohammad Masoud NIKKAR
Korean Journal of Urology 2013;54(3):172-176
PURPOSE: Percutaneous nephrolithotomy (PCNL) has been the preferred procedure for the removal of large renal stones in Iran since 1990. Recently, we encountered a series of devastating neurologic complications during PCNL, including paraplegia and hemiplegia. There are several reports of neurologic complications following PCNL owing to paradoxical air emboli, but there are no reports of paraplegia following PCNL. MATERIALS AND METHODS: We retrospectively reviewed the medical records of patients who had undergone PCNL in 13 different endourologic centers and retrieved data related to neurologic complications after PCNL, including coma, paraplegia, hemiplegia, and quadriplegia. RESULTS: The total number of PCNL procedures in these 13 centers was 30,666. Among these procedures, 11 cases were complicated by neurologic events, and four of these cases experienced paraplegia. All events happened with the patient in the prone position with the use of general anesthesia and in the presence of air injection. There were no reports of neurologic complications in PCNL procedures performed with the patient under general anesthesia and in the prone position and with contrast injection. CONCLUSIONS: It can be assumed that using room air to opacify the collecting system played a major role in the occurrence of these complications. Likewise, the prone position and general anesthesia may predispose to these events in the presence of air injection.
Anesthesia, General
;
Coma
;
Hemiplegia
;
Humans
;
Iran
;
Medical Records
;
Nephrostomy, Percutaneous
;
Neurologic Manifestations
;
Paraplegia
;
Prone Position
;
Retrospective Studies
2.Effects of COVID-19 pandemics on urinary metabolites in kidney stone patients: our kidney stone prevention clinic experience.
Sanaz TAVASOLI ; Nasrin BORUMANDNIA ; Abbas BASIRI ; Maryam TAHERI
Environmental Health and Preventive Medicine 2021;26(1):112-112
BACKGROUND:
The dietary habits and lifestyle changes during the COVID-19 pandemic could affect the urinary risk factors in kidney stone formers. In this study, we investigated the effects of the COVID-19 pandemic on 24-h urine metabolites, as a surrogate for dietary intake, in patients with kidney stones, in Tehran, Iran.
METHODS:
We evaluated the medical records of all patients with urolithiasis who visited in our stone prevention clinic from the beginning of COVID-19 in Iran to 1 year later (Feb 2020-Feb 2021) and compared it with the patients' medical records in the same period a year before COVID-19 (Feb 2019-Feb 2020).
RESULTS:
The results of our stone prevention clinic showed a decrease in the number of visits during COVID-19. Twenty-four-hour urine urea, sodium, and potassium were significantly lower, and 24-h urine magnesium was significantly higher during COVID-19. Higher 24-h urine oxalate was only shown in patients with the first-time visit, whereas lower 24-h urine uric acid and citrate were only shown in patients with the follow-up visits.
CONCLUSIONS
COVID-19 pandemics may change some of the dietary habits of the patients, including lower salt, protein, and fruit and vegetable intake. Although economic issues, restricted access, or sanitation issues may be the reason for the undesirable dietary changes, the importance of a quality diet should be discussed with all patients, as possible. Since the number of patients visited in the stone clinic was lower during COVID-19, virtual visits could be an excellent alternative to motivate patients with kidney stones.
COVID-19
;
Humans
;
Iran/epidemiology*
;
Kidney
;
Kidney Calculi/prevention & control*
;
Pandemics
;
Risk Factors
;
SARS-CoV-2